Noninvasive detection of myocardial inflammation can be challenging. Up to 73% of patients recovered from COVID-19 had increased native T1 on cardiac MRI1 representing inflammation or edema. Therefore, we tested whether hyperpolarized (HP) [1-13C]pyruvate detectis post-COVID-19 inflammation in the myocardium. HP [1-13C]lactate has been suggested as a surrogate imaging marker of inflammation in the heart2,3, attributed to increased glycolytic activity in infiltrating white cells plus a possible increase in activity of lactate dehydrogenase. We demonstrate the feasibility of imaging with HP [1-13C]pyruvate as noninvasive method to detect metabolic changes that may identify cardiac inflammation in the convalescent stage after COVID-19.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords